ArticleBMJ open2022

Mitigating Infectious morbidity and Growth deficits in HIV-exposed uninfected infanTs with human Milk Oligosaccharide (MIGH-T MO): a randomised trial protocol.

Rupak Shivakoti et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.